Alexis Peyroles
Net worth: 2 M $ as of 31/05/2026
Net worth: 2 M $ as of 31/05/2026
Alexis Peyroles is the founder of Inside Therapeutics SAS, serving as Chairman & Chief Financial Officer since 2022.
Current jobs include Chief Executive Officer at Ose Immunotherapeutics, Inc., Chief Executive Officer & Director at Betaglue Technologies SpA starting in 2025, and Chairman at Aperana Consulting SAS. Former jobs include Chief Executive Officer & Director at OSE Immunotherapeutics SA from 2018 to 2022, Chief Executive Officer at Guerbet Imagem do Brasil Ltda., Manager-Financial Control at Guerbet SA, Head-Financial Control-Baltic States at Sanofi-Aventis Japan, Head-Eastern Europe Business Development at Sanofi-Aventis France SA, and CFO & Head-Business Development at Orphan Synergy Europe-Pharma SA. Education includes an undergraduate degree from École des Hautes Études Commerciales du Nord and an MBA from Imperial College Business School.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 30/09/2025 | 293,848 ( 1.3% ) | 2 M $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
Aperana Consulting SAS | Chairman | - |
Ose Immunotherapeutics, Inc. | Chief Executive Officer | - |
Betaglue Technologies SpA
Betaglue Technologies SpA Miscellaneous Commercial ServicesCommercial Services Provides medical technology research and oncology research services | Chief Executive Officer | 22/09/2025 |
| Companies | Position | End |
|---|---|---|
| OSE IMMUNOTHERAPEUTICS | Chief Executive Officer | 16/01/2022 |
Guerbet Imagem do Brasil Ltda. | Chief Executive Officer | - |
Sanofi-Aventis Japan | Comptroller/Controller/Auditor | - |
| GUERBET | Comptroller/Controller/Auditor | - |
Sanofi-Aventis France SA
Sanofi-Aventis France SA Medical DistributorsDistribution Services Wholesales pharmaceutical products | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 11 |
|---|---|
Guerbet SA
Guerbet SA Medical SpecialtiesHealth Technology Engages in research, development and production of X-Rays and its by products | Health Technology |
Sanofi-Aventis Japan | |
École des Hautes Études Commerciales du Nord
École des Hautes Études Commerciales du Nord Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sanofi-Aventis France SA
Sanofi-Aventis France SA Medical DistributorsDistribution Services Wholesales pharmaceutical products | Distribution Services |
Orphan Synergy Europe-Pharma SA
Orphan Synergy Europe-Pharma SA Pharmaceuticals: MajorHealth Technology Develops immunotherapy products for late-stage cancers | Health Technology |
Imperial College Business School
Imperial College Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aperana Consulting SAS | |
OSE Immunotherapeutics SA
OSE Immunotherapeutics SA Pharmaceuticals: MajorHealth Technology Develops immunotherapy products for late-stage cancers | Health Technology |
Betaglue Technologies SpA
Betaglue Technologies SpA Miscellaneous Commercial ServicesCommercial Services Provides medical technology research and oncology research services | Commercial Services |
Ose Immunotherapeutics, Inc. | |
Guerbet Imagem do Brasil Ltda. |
Select your edition
All financial news and data tailored to specific country editions